Euroeyes International Eye Clinic Ltd
HKEX:1846
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4.17
5.8
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Euroeyes International Eye Clinic Ltd
Income from Continuing Operations
Euroeyes International Eye Clinic Ltd
Income from Continuing Operations Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
E
|
Euroeyes International Eye Clinic Ltd
HKEX:1846
|
Income from Continuing Operations
HK$133.3m
|
CAGR 3-Years
28%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
Income from Continuing Operations
€762.4m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-1%
|
|
Fresenius SE & Co KGaA
XETRA:FRE
|
Income from Continuing Operations
€379m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
-14%
|
||
Vita 34 AG
XETRA:V3V
|
Income from Continuing Operations
-€176k
|
CAGR 3-Years
-53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Synlab AG
XETRA:SYAB
|
Income from Continuing Operations
€93m
|
CAGR 3-Years
35%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
||
Fresenius Medical Care AG
XMUN:FME
|
Income from Continuing Operations
€762.4m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-1%
|
Euroeyes International Eye Clinic Ltd
Glance View
EuroEyes International Eye Clinic Ltd. engages in the provision of vision correction services. The company is headquartered in Hamburg, Hamburg. The company went IPO on 2019-10-15. The firm provides various services for vision correction, such as refractive laser surgery, phakic lens surgery and lens exchange surgery. The firm operates in Germany, Denmark and China.
See Also
What is Euroeyes International Eye Clinic Ltd's Income from Continuing Operations?
Income from Continuing Operations
133.3m
HKD
Based on the financial report for Dec 31, 2023, Euroeyes International Eye Clinic Ltd's Income from Continuing Operations amounts to 133.3m HKD.
What is Euroeyes International Eye Clinic Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
30%
Over the last year, the Income from Continuing Operations growth was 60%. The average annual Income from Continuing Operations growth rates for Euroeyes International Eye Clinic Ltd have been 28% over the past three years , 30% over the past five years .